Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease

BACKGROUND: Down syndrome (DS), caused by chromosome 21 trisomy, is associated with an ultra-high risk of dementia due to Alzheimer’s disease (AD), driven by amyloid precursor protein (APP) gene triplication. Understanding relevant molecular differences between those with DS, those with sporadic AD...

Descripción completa

Detalles Bibliográficos
Autores principales: Startin, Carla M., Ashton, Nicholas J., Hamburg, Sarah, Hithersay, Rosalyn, Wiseman, Frances K., Mok, Kin Y., Hardy, John, Lleó, Alberto, Lovestone, Simon, Parnetti, Lucilla, Zetterberg, Henrik, Hye, Abdul, Strydom, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429702/
https://www.ncbi.nlm.nih.gov/pubmed/30902060
http://dx.doi.org/10.1186/s13195-019-0477-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429702/
https://www.ncbi.nlm.nih.gov/pubmed/30902060
http://dx.doi.org/10.1186/s13195-019-0477-0

Ejemplares similares